Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Not applicableUnknownNCT05531266
What this trial is testing

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

Who this might be right for
aGVHD
Institute of Hematology & Blood Diseases Hospital, China 182
Testing effectiveness (Phase 2)UnknownNCT01131429
What this trial is testing

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Neoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00251472
What this trial is testing

A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Veeda Oncology 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769
What this trial is testing

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 121
Testing effectiveness (Phase 2)Ended earlyNCT03605069
What this trial is testing

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant
Phoenicis Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT01991873
What this trial is testing

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 387
Large-scale testing (Phase 3)Study completedNCT00095394
What this trial is testing

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

Who this might be right for
Hypertension
Bristol-Myers Squibb 645
Testing effectiveness (Phase 2)Study completedNCT00796757
What this trial is testing

Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 146
Large-scale testing (Phase 3)Study completedNCT00643851
What this trial is testing

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Who this might be right for
Type 2 Diabetes
AstraZeneca 994
Not applicableUnknownNCT05441995
What this trial is testing

Cryotherapy Efficacy During Pulp Therapy of the Mandibular First Permanent Molars in Children

Who this might be right for
Cryotherapy EffectIrreversible PulpitisPain
Minia University 140
Not applicableStudy completedNCT03841175
What this trial is testing

Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers

Who this might be right for
Cancer of Head and Neck
University Hospital, Brest 477
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableUnknownNCT06298045
What this trial is testing

Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy

Who this might be right for
Stable Angina
Servier Affaires Médicales 600
Large-scale testing (Phase 3)Study completedNCT00069095
What this trial is testing

Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 2,035
Large-scale testing (Phase 3)Study completedNCT00002777
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 342
Post-approval studies (Phase 4)Not Yet RecruitingNCT06956092
What this trial is testing

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
B Cell Lymphoma (BCL)
Zhengzhou University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07032792
What this trial is testing

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

Who this might be right for
Cardiac DiseaseSurgeryBleeding
Northwell Health 140
Not applicableStudy completedNCT02101372
What this trial is testing

Intervention Module AGES

Who this might be right for
Psychosis
Celso Arango 55
Testing effectiveness (Phase 2)WithdrawnNCT05019677
What this trial is testing

GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University
Next Page